Defunct Company
Total Trials
3
As Lead Sponsor
2
As Collaborator
1
Total Enrollment
146
NCT02670824
Safety Study of CN-105 Neuroprotective Peptide for Intracerebral Hemorrhage
Phase: Phase 1
Role: Lead Sponsor
Start: Dec 31, 2015
Completion: Aug 31, 2016
NCT03168581
A Proof of Concept Study to Evaluate CN-105 in ICH Patients
Phase: Phase 2
Start: Aug 28, 2017
Completion: Jan 25, 2020
NCT03711903
Evaluation of CN-105 in Subject With Acute Supratentorial Intracerebral Hemorrhage
Role: Collaborator
Start: Mar 24, 2019
Completion: Jun 16, 2022